Search

everythinglearnresearchcommunity

for

Search:↓

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

A new hydrogel with stem cells from the human umbilical cord speeds up healing in diabetic wounds.

Thyroid problems can cause hair loss and change hair texture.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Skin organoids from stem cells could better mimic real skin but face challenges.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Cyclosporine may cause hair loss, so patients need monitoring.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

The document provides 70 multiple choice questions to improve haematology skills.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Dental pulp stem cells might not reliably become neurons.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.